- Title
- Licorice (glycyrrhiza glabra) extracts-suitable pharmacological interventions for covid-19? a review
- Creator
- Abraham, Joji; Florentine, Singarayer
- Date
- 2021
- Type
- Text; Journal article; Review
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/180970
- Identifier
- vital:15850
- Identifier
-
https://doi.org/10.3390/plants10122600
- Identifier
- ISBN:2223-7747 (ISSN)
- Abstract
- Even though vaccination has started against COVID-19, people should continue maintaining personal and social caution as it takes months or years to get everyone vaccinated, and we are not sure how long the vaccine remains efficacious. In order to contribute to the mitigation of COVID-19 symptoms, the pharmaceutical industry aims to develop antiviral drugs to inhibit the SARS-CoV-2 replication and produce anti-inflammatory medications that will inhibit the acute respiratory distress syndrome (ARDS), which is the primary cause of mortality among the COVID-19 patients. In reference to these tasks, this article considers the properties of a medicinal plant named licorice (Glycyrrhiza glabra), whose phytochemicals have shown both antiviral and anti-inflammatory tendencies through previous studies. All the literature was selected through extensive search in various databases such as google scholar, Scopus, the Web of Science, and PubMed. In addition to the antiviral and anti-inflammatory properties, one of the licorice components has an autophagy-enhancing mechanism that studies have suggested to be necessary for COVID-19 treatment. Based on reviewing relevant professional and historical literature regarding the medicinal properties of licorice, it is suggested that it may be worthwhile to conduct in vitro and in vivo studies, including clinical trials with glycyrrhizic and glycyrrhetinic acids together with other flavonoids found in licorice, as there is the potentiality to provide natural interventions against COVID-19 symptoms. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
- Publisher
- MDPI
- Relation
- Plants Vol. 10, no. 12 (2021), p.
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- https://creativecommons.org/licenses/by/4.0/
- Rights
- Copyright © 2021 by the authors.
- Rights
- Open Access
- Subject
- 0607 Plant Biology; Anti-inflammatory drug; Antiviral drug; ARDS; Coronavirus; Glycyrrhetinic acid; Glycyrrhizic acid; Medicinal plants; SARS-CoV-2 pandemic
- Full Text
- Reviewed
- Hits: 1599
- Visitors: 1562
- Downloads: 104
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published version | 2 MB | Adobe Acrobat PDF | View Details Download |